Robert Becker
Corporate Officer/Principal chez Lubrizol Life Science Health
Profil
Robert Becker is currently the VP-Biopharmaceutical Sales & Business Development at Lubrizol Life Science Health.
He previously worked as Vice President-Corporate Development at Sanofi Pasteur, Principal at Loyola University of Chicago and the University of Illinois, and Vice President-Business Development at VaxInnate Corp.
Becker holds an MBA from The Trustees of Columbia University in The City of New York and a doctorate from the University of Kansas.
Postes actifs de Robert Becker
| Sociétés | Poste | Début |
|---|---|---|
Lubrizol Life Science Health
 Lubrizol Life Science Health Pharmaceuticals: MajorHealth Technology Lubrizol Life Science Health. provides drug development manufacturing and delivery services. It offers drug product formulation and a comprehensive suite of supporting services including analytic, bioanalytic, physical characterization and manufacturing. The company was founded by Mark A. Mitchnick in 1991 and is headquartered in Bethlehem, PA. | Corporate Officer/Principal | 04/02/2014 |
Anciens postes connus de Robert Becker
| Sociétés | Poste | Fin |
|---|---|---|
| University of Illinois | Corporate Officer/Principal | - |
Sanofi Pasteur, Inc.
 Sanofi Pasteur, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Pasteur, Inc. provides vaccines for the prevention and treatment of diseases. It develops and manufactures influenza vaccine against the pandemic influenza virus. The company was founded in 1897 and is headquartered in Swiftwater, PA. | Corporate Officer/Principal | - |
| Loyola University of Chicago | Corporate Officer/Principal | - |
VaxInnate Corp.
 VaxInnate Corp. Pharmaceuticals: MajorHealth Technology VaxInnate Corp. develops novel, proprietary vaccines for infectious diseases. It engages in the development and production of vaccines for pandemic and seasonal influenza diseases. The firm's products include Flagellin.HuHA and flagellin.AvHA, which are fusion proteins linking a potent immune stimulator, the bacterial protein flagellin, with immunoprotective domain of viral hemagglutinin. The company was founded by Ruslan Medzhitov, Michael I. Sherman and Richard Flavell in 2002 and is headquartered in Cranbury, NJ. | Corporate Officer/Principal | - |
Formation de Robert Becker
| University of Kansas | Doctorate Degree |
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
VaxInnate Corp.
VaxInnate Corp. Pharmaceuticals: MajorHealth Technology VaxInnate Corp. develops novel, proprietary vaccines for infectious diseases. It engages in the development and production of vaccines for pandemic and seasonal influenza diseases. The firm's products include Flagellin.HuHA and flagellin.AvHA, which are fusion proteins linking a potent immune stimulator, the bacterial protein flagellin, with immunoprotective domain of viral hemagglutinin. The company was founded by Ruslan Medzhitov, Michael I. Sherman and Richard Flavell in 2002 and is headquartered in Cranbury, NJ. | Health Technology |
Sanofi Pasteur, Inc.
Sanofi Pasteur, Inc. Pharmaceuticals: MajorHealth Technology Sanofi Pasteur, Inc. provides vaccines for the prevention and treatment of diseases. It develops and manufactures influenza vaccine against the pandemic influenza virus. The company was founded in 1897 and is headquartered in Swiftwater, PA. | Health Technology |
Lubrizol Life Science Health
Lubrizol Life Science Health Pharmaceuticals: MajorHealth Technology Lubrizol Life Science Health. provides drug development manufacturing and delivery services. It offers drug product formulation and a comprehensive suite of supporting services including analytic, bioanalytic, physical characterization and manufacturing. The company was founded by Mark A. Mitchnick in 1991 and is headquartered in Bethlehem, PA. | Health Technology |
